What Pharma Wants From IT Today
Ellen Julian
Life Science Insights
See results from the 2005 Pharmaceutical Executive/Life Science Insights Information Technology Survey.
Informatics Rules
MaryJo Zaborowski, Juergen Hammer, and Gloria Lawler
Roche
Roche's Global Research Informatics organization, formed to facilitate data sharing, is helping to put the company's global network of scientists on the same page.
The Source of Truth
Patrick Clinton
Editor-in-Chief
IT solutions for ensuring compliance are top of mind for pharma execs—and the technology vendors that supply them.
In Search of the Holy Grail
Rob Case
Procter & Gamble Pharmaceuticals
Data integration is improving overall clinical trials management, but quantifying ROI remains a ways off.
Shedding Wings
In this Q&A, Pharm Exec talks to John Hagel about his latest book, and about why he thinks outsourcing decisions should be driven by quality improvement—not cost reduction.
News
GSK's new facility to focus on external drug discovery programs » Medsite's new partnership with Yahoo! » Legislators support FDA's authority to make post-marketing labeling changes. » Tension heightens between PBMs and pharmacists.
Data
Compliance especially important for diabetics » Trust in online health information on the rise.
Thought Leaders
At the helm of Sirius Laboratories, Garry Barnes preaches specialty sales force excellence.
Washington Report
The e-precribing bandwagon is filling up fast.
Jill Wechsler
Global Report
Industry and pharmaceutical wholesalers are both holding out for a ruling on parallel trade in Europe—just not the same one.
Sarah Houlton
Leadership
Leaders today must do more than just keep ahead of trends—they must set them.
Sander A. Flaum
Flaum Partners
Legal Forum
If you provide misleading information and an investor loses, are you to blame?
Pamela Palmer and Jeff Hammel
Latham & Watkins
Direct to Consumer
To regain trust, pharma must invest further in connecting corporate brands more directly with product brands.
Ken Dec
PreVision
Marketing to Professionals
The government plans to link clinical trial evidence with real-world drug applications, says one member of the Medicare Coverage Advisory Committee.
Bryan Luce
United BioSource Corporation
Alternative Media
Perks are in store for pharma companies that jump on the expanding medium of health information portals.
Debrianna Obara
Avenue A/Razorfish
Sales Management
Incentive management helped Wyeth align its reps' rewards with sales strategies after undergoing a merger.
Mark Stiffler
Synergy
From the Editor
The push to ban ED drugs from Medicare reimbursement isn't about their "lifestyle" classification.
Patrick Clinton
Editor-in-Chief
Back Page
Pharma has more in common with tobacco than it may think.
Sarah Wealleans
Landor Associates
People Update
Calendar of Events
Advertisers Index
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.